Topics

Health services administration

Environmental health Perspective 7 April 2025 Open Access

The potential of maternal and child health service data in Australia: how lessons from the COVID‐19 pandemic can accelerate data‐informed decision making

A discussion on the possibility and urgency of using linked maternal and child health data, with Victoria and South Australia as case studies, while there is a political window of opportunity for collaborative action

Ashleigh Shipton · Meredith O'Connor · Melissa Wake · Sharon Goldfeld · Helen Lees · Catina Adams · Kristina Edvardsson · Leesa Hooker · Jatender Mohal · Rhiannon M Pilkington · Fiona K Mensah

Mja2 52630
Environmental health Perspective 7 April 2025 Open Access

The 2024 report of the MJALancet Countdown on health and climate change: Australia emerging as a hotspot for litigation

The next five years are pivotal in reducing greenhouse gas emissions and transitioning energy production to renewables; Australia is making progress in this direction, but the remaining deficiencies in Australia’s response to the health and climate change threat must be addressed

Paul J Beggs · Alistair J Woodward · Stefan Trueck · Martina K Linnenluecke · Hilary Bambrick · Anthony G Capon · Zerina Lokmic‐Tomkins · Jacqueline Peel · Kathryn Bowen · Ivan C Hanigan · Nicolas Borchers Arriagada · Troy J Cross · Sharon Friel · Donna Green · Maddie Heenan · Ollie Jay · Harry Kennard · Arunima Malik · Celia McMichael · Mark Stevenson · Sotiris Vardoulakis · Aditya Vyas · Marina B Romanello · Maria Walawender · Ying Zhang

Mja2 52616
Statistics Perspective 31 March 2025 Open Access

Dismantling barriers to research and clinical care for individuals with a vision impairment

Accessibility in research is an ongoing commitment that will continue to change based on the needs and preferences of the community. We must weigh up the impact of incorporating accessibility practices in research with the social cost of forgoing them

Eden G Robertson · Kate Hetherington · Meredith Prain · Julia Hall · Leighton Boyd AM · Rosemary Boyd OAM · Emily Shepard · Hollie Feller · Sally Karandrews · Fleur O'Hare · Kanae Yamamoto · Matthew P Simunovic · Robyn V Jamieson · Alan Ma · Lauren Ayton AM · Anai Gonzalez‐Cordero

Mja2 52627
Urology Research 17 March 2025 Open Access

Closing the gap in kidney disease: validating the reporting of Aboriginal and/or Torres Strait Islander identification in a clinical quality registry using linked data

Integrating data to improve equity metrics in ANZDATA, including ethnicity and cultural identity, is vital for improving the health of Indigenous people

Heather J Baldwin · Nicole De La Mata · Grant Sara · Faye McMillan · Brett Biles · Jianyun Wu · Paul Lawton · Stephen McDonald · Angela C Webster

Mja2 52613

The impact of pay‐for‐performance incentives for stroke unit access on public hospital costs and use, Queensland, 2012–17: interrupted time series analysis

Improving quality of care without increasing costs or hospital demand, the pay-for-performance program increased value for health care spending

Rohan Grimley · Joosup Kim · Helen M Dewey · Nadine E Andrew · Taya A Collyer · Eleanor S Horton · Greg Cadigan · Dominique A Cadilhac

Medical practices Perspective 3 March 2025 Open Access

Decentralised COVID‐19 molecular point‐of‐care testing: lessons from implementing a primary care‐based network in remote Australian communities

The First Nations COVID-19 molecular point-of-care (POC) testing program was part of the Australian pandemic response, ensuring equitable testing access and minimising diagnosis delays. To inform future pandemic preparedness, we reviewed the POC framework to provide key recommendations.

Belinda Hengel · Rebecca J Guy · Dawn Casey · Lorraine Anderson · Kirsty Smith · Kelly Andrewartha · Tanya D Applegate · Amit Saha · Philip Cunningham · Lucas DeToca · William D Rawlinson · Marianne Martinello · Annie Tangey · Prital Patel · Mark DS Shephard · Susan Matthews · Louise Causer

The role of GLP‐1 receptor agonists in the management of obesity: risks and opportunities for the Australian health care system

The use of glucagon-like peptide-1 receptor agonists in the treatment of obesity has the potential to impact one-third of Australians. This warrants due consideration and planning for future funding models, systems and models of care to ensure equitable access

Christopher Kanellis · Kyle Williams · Darcy Q Holt · Jennifer Wong · Rachel David · Ravi Carothers · Suong Le

Subscribe to MJA email alerts

No spam, you can unsubscribe anytime you want.

By providing your information, you agree to our Terms of Use and our Privacy Policy.

Thanks for Subscribing! Tell us more

Your email updates will use your name.

Good one! Your updates are coming

Thank you for subscribing to the MJA email alerts. Receive the latest content in your inbox.